Discovery of small molecules targeting the tandem tudor domain of the epigenetic factor UHRF1 using fragment-based ligand discovery
Abstract Despite the established roles of the epigenetic factor UHRF1 in oncogenesis, no UHRF1-targeting therapeutics have been reported to date. In this study, we use fragment-based ligand discovery to identify novel scaffolds for targeting the isolated UHRF1 tandem Tudor domain (TTD), which recogn...
Guardado en:
Autores principales: | Lyra Chang, James Campbell, Idris O. Raji, Shiva K. R. Guduru, Prasanna Kandel, Michelle Nguyen, Steven Liu, Kevin Tran, Navneet K. Venugopal, Bethany C. Taylor, Matthew V. Holt, Nicolas L. Young, Errol L. G. Samuel, Prashi Jain, Conrad Santini, Banumathi Sankaran, Kevin R. MacKenzie, Damian W. Young |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5972f93c7d5b4a20bcf0f3bca4897227 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Structural basis for recognition of 53BP1 tandem Tudor domain by TIRR
por: Yaxin Dai, et al.
Publicado: (2018) -
Discovery and quality analysis of a comprehensive set of structural variants and short tandem repeats
por: David Jakubosky, et al.
Publicado: (2020) -
Price Discovery of Consignment Auctions for Emission Permits
por: Jae-Do Song, et al.
Publicado: (2021) - Discovery (00123641)
- Drug Discovery